Complete macroscopic surgical cytoreduction improves survival in advanced ovarian cancer.
However, our previous results suggest that the survival benefits of aggressive surgery to achieve complete macroscopic resection may vary across different subgroups.
This study aimed to identify a potential poor-prognosis subgroup among patients with complete macroscopic resection.
